CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 7 | 11 | +4 |
| Shares | 40.6K | 512.8K | +472.2K (+1,163.1%) |
| Value | $55.2K | $421.8K | +$366.6K (+664.0%) |
New holders (5)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 406,000 | $334.9K | 0.01% |
| Virtu Financial LLC | 23,348 | $19.0K | 0.00% |
| Geode Capital Management, LLC | 17,871 | $14.7K | 0.00% |
| Two Sigma Securities, LLC | 15,633 | $12.9K | 0.00% |
| HRT Financial LP | 10,863 | $8.00K | 0.00% |
Sold out (1)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Ground Swell Capital, LLC | 11,341 | $15.4K |